16 Ovarian Cancer Research Foundation As another means to close the funding gap, we have proactively secured several collaborative partnerships. Some of these partnerships are with other cancer research organisations, where we have secured matched funding for ovarian cancer research as the minimum baseline. We have also joined forces with individual researchers and research institutions to make applications for Government funding with the OCRF acting as the collaborative partner. While we committed over $450,000 in these partnerships for the year, we also shared our resources and assets as part of our commitment to the partnerships. Our most recent endeavours are listed below: New Research Grants Research Priority Collab Partner Name Institute Research title Project Length Current Year Cost per year ACRF Bio21 Institute Australian Cancer Research Foundation Facility for Innovative Cancer Drug Discovery 3 3 $111,198 ACRF Australian Cancer Research Foundation Program for Resolving Cancer Complexity and Therapeutic Resistance. 3 2 $116,500 NBCF Prof Khanna QMIR Development of a novel combination therapy to target triple-negative breast and high-grade serous ovarian cancers 3 1 $83,951 CCV Dr Barker WEHI Identifying new treatment options for the rare and aggressive ovarian carcinosarcoma. 3 1 $50,000 MRFF Dr Chu Hudson Institute Towards a New Era in Granulosa Cell Tumour Research: Patient Driven Outcomes, Genomics, Diagnostics & Therapeutics. 4 1 $29,500 MRFF Dr Hooper Uni of Qld A new radio-imaging agent to guide targeted therapy for epithelial ovarian cancer. 4 1 $15,000 MRFF Assoc Prof Salomon Uni of Qld Ovarian cancer early detection, monitoring and therapeutic intervention using extracellular vesicles. 4 1 $60,000